Conditions required for the bactericidal activity of 4-quinolones against Serratia marcescens
C. S. Lewin, J. T. Smith
Abstract
C. S. Lewin, J. T. Smith
Abstract
The conditions required to kill Serratia marcescens with nalidixic acid, ciprofloxacin, norfloxacin or ofloxacin were determined in nutrient broth and in phosphate-buffered saline. They were found to be similar to the conditions required for these 4-quinolones to kill Escherichia coli. Bacterial RNA synthesis and bacterial cell division were essential for the bactericidal activity of nalidixic acid but all three fluoroquinolones were bactericidal against non-dividing S. marcescens. However, as with E. coli, bacterial RNA synthesis was essential for the bactericidal activity of norfloxacin though this was not required to kill S. marcescens with ciprofloxacin or ofloxacin.
OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The conditions required to kill Serratia marcescens with nalidixic acid, ciprofloxacin, norfloxacin or ofloxacin were determined in nutrient broth and in phosphate-buffered saline. They were found to be similar to the conditions required for these 4-quinolones to kill Escherichia coli. Bacterial RNA synthesis and bacterial cell division were essential for the bactericidal activity of nalidixic acid but all three fluoroquinolones were bactericidal against non-dividing S. marcescens. However, as with E. coli, bacterial RNA synthesis was essential for the bactericidal activity of norfloxacin though this was not required to kill S. marcescens with ciprofloxacin or ofloxacin.
Key concepts: Serratia marcescens, Nalidixic acid, Norfloxacin, Microbiology, Ciprofloxacin, Ofloxacin, Escherichia coli, Antibacterial agent